发明名称 |
INSULIN SECRETAGOGUE |
摘要 |
<p>Provided is an insulin secretagogue which is effective in preventing diabetes and the like and which is very safe and free of concern of side effects even when ingested continuously. This insulin secretagogue contains, as an active ingredient, any of a phospholipid, a sucrose fatty acid ester, an HLB-4 to 15 polyglycerin fatty acid ester, or glycerin mono fatty acid ester, and is therefore very safe and free of concern of side effects even when ingested continuously. The phospholipid is preferably lecithin derived from soybeans. The HLB of the sucrose fatty acid ester is preferably 4 to 16. The carbon number of the constituent fatty acid of the glycerin mono fatty acid ester is preferably 8 to 12.</p> |
申请公布号 |
WO2012073965(A1) |
申请公布日期 |
2012.06.07 |
申请号 |
WO2011JP77556 |
申请日期 |
2011.11.29 |
申请人 |
THE NISSHIN OILLIO GROUP, LTD.;AOYAMA, TOSHIAKI;TERADA, SHIN |
发明人 |
AOYAMA, TOSHIAKI;TERADA, SHIN |
分类号 |
A61K31/683;A61K31/23;A61P3/10 |
主分类号 |
A61K31/683 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|